1. Home
  2. FRSH vs OGN Comparison

FRSH vs OGN Comparison

Compare FRSH & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshworks Inc.

FRSH

Freshworks Inc.

N/A

Current Price

$12.04

Market Cap

4.0B

Sector

Technology

ML Signal

N/A

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$13.86

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FRSH
OGN
Founded
2010
1923
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.6B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
FRSH
OGN
Price
$12.04
$13.86
Analyst Decision
Buy
Hold
Analyst Count
17
4
Target Price
★ $16.62
$10.33
AVG Volume (30 Days)
★ 5.0M
2.3M
Earning Date
11-03-2026
10-30-2026
Dividend Yield
N/A
★ 0.58%
EPS Growth
★ 296.88
N/A
EPS
0.06
★ 1.56
Revenue
$838,809,000.00
★ $6,216,000,000.00
Revenue This Year
$15.08
N/A
Revenue Next Year
$13.96
$2.07
P/E Ratio
$203.75
★ $8.87
Revenue Growth
★ 16.43
N/A
52 Week Low
$6.79
$5.69
52 Week High
$15.51
$13.88

Technical Indicators

Market Signals
Indicator
FRSH
OGN
Relative Strength Index (RSI) 31.67 62.71
Support Level $11.83 $13.72
Resistance Level $12.20 N/A
Average True Range (ATR) 0.63 0.04
MACD -0.40 0.01
Stochastic Oscillator 3.61 82.14

Price Performance

Historical Comparison
FRSH
OGN

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions. It derives maximum revenue from North America.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: